Chemical Research in Toxicology
-
Publication Venue For
-
A Classification Model to Identify Direct-Acting Mutagenic Polycyclic Aromatic Hydrocarbon Transformation Products..
34:2273-2286.
2021
-
Food-Grade TiO2
Particles Generate Intracellular Superoxide and Alter Epigenetic Modifiers in Human Lung Cells..
33:2872-2879.
2020
-
In Vitro
Metabolism of Isopropylated and tert
-Butylated Triarylphosphate Esters Using Human Liver Subcellular Fractions..
33:1428-1441.
2020
-
Disruption of type 2 iodothyronine deiodinase activity in cultured human glial cells by polybrominated diphenyl ethers..
28:1265-1274.
2015
-
Cellular toxicity associated with exposure to perfluorinated carboxylates (PFCAs) and their metabolic precursors..
27:42-50.
2014
-
Inhibition of thyroid hormone sulfotransferase activity by brominated flame retardants and halogenated phenolics..
26:1692-1702.
2013
-
Detection of acrolein-derived cyclic DNA adducts in human cells by monoclonal antibodies..
25:2788-2795.
2012
-
In vitro metabolism of the brominated flame retardants 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB) and bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate (TBPH) in human and rat tissues..
25:1435-1441.
2012
-
Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management..
25:1287-1302.
2012
-
DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1..
23:1151-1162.
2010
-
Phospholipid-protein adducts of lipid peroxidation: synthesis and study of new biotinylated phosphatidylcholines..
20:227-234.
2007
-
Erratum: Replication of N2-ethyldeoxyguanosine DNA adducts in the human embryonic kidney cell line 23 (Chemical Research in Toxicology (2006) 19,7, (960-967)).
20:164.
2007
-
Replication of N2-ethyldeoxyguanosine DNA adducts in the human embryonic kidney cell line 293..
19:960-967.
2006
-
Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats..
17:1177-1189.
2004
-
Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A)..
17:435-445.
2004
-
The N2-ethylguanine and the O6-ethyl- and O6-methylguanine lesions in DNA: contrasting responses from the "bypass" DNA polymerase eta and the replicative DNA polymerase alpha..
16:1616-1623.
2003
-
Detection and characterization of a glutathione conjugate of ochratoxin A..
15:1581-1588.
2002
-
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4..
14:1596-1603.
2001
-
Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone..
14:25-33.
2001
-
Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants..
12:442-449.
1999
-
Evidence for metabolism of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product, by cysteine conjugate beta-lyase..
9:696-702.
1996
-
Identification and quantification of regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein..
9:737-744.
1996
-
Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane..
9:555-561.
1996
-
Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy..
1:179-185.
1988